On Thursday, Shares of Pfizer Inc. (NYSE:PFE), lost -0.08% to $35.73.
Pfizer stated financial results for second-quarter 2015 and declared enhances to the midpoints of its 2015 financial guidance(3) ranges for stated revenues(1) and stated(1) and adjusted(2) diluted EPS.
The company manages its commercial operations through two distinct businesses: an Innovative Products business and an Established Products business. The Innovative Products business is composed of two operating segments: the Global Innovative Pharmaceutical segment (GIP)(4) and the Global Vaccines, Oncology and Consumer Healthcare segment (VOC)(4). The Established Products business comprises of the Global Established Pharmaceutical segment (GEP)(4). Financial results for each of these segments are presented in the Operating Segment Information section.
Ian Read, Chairman and Chief Executive Officer, stated, “Our second-quarter and year-to-date financial performance is the result of continued business momentum, driven by solid execution of recent product launches in our Innovative Products business, notably Ibrance and Prevnar 13 in adults in the U.S., together with continued growth from Eliquis and Xeljanz, raised focus on and support of growth initiatives within our Established Products business in addition to shareholder-friendly capital allocation. For the remainder of 2015, we look forward to concluding the pending acquisition of Hospira, Inc. (Hospira), which we expect will meaningfully enhance our Established Products business, particularly in sterile injectables and biosimilars, and ongoing to advance our late-stage pipeline in important areas such as oncology and immuno-oncology, vaccines, rare disease, cardiovascular disease and biosimilars. I continue to see both of our businesses as highly focused, well managed and competitively positioned in their key markets.”
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments.
Shares of JPMorgan Chase & Co. (NYSE:JPM), inclined 0.15% to $69.04, during its last trading session.
Chase declared that as part of its multi-year agreement with Walt Disney Parks and Resorts, U.S. it continues as the presenting sponsor of the Epcot International Food & Wine Festival. The festival, running from September 25 through November 16, 2015, will welcome celebrity chefs, debut new marketplaces and tastes from around the world and celebrate Guests’ favorite dining traditions.
The sponsorship of the Epcot International Food & Wine Festival extends Chase’s relationship with Disney as the issuer of the Disney Premier Visa Credit Card, Disney Rewards Visa Credit Card and Disney Visa Debit Card. Chase debit and credit cardmembers, counting Disney Visa Cardmembers, again have exclusive access to complimentary, non-alcoholic refreshments, charging stations and interactive fun at the Chase Lounge.1 The lounge, located on the third floor of the American Adventure Pavilion within the Epcot World Showcase, will be open daily during the Festival from 11 a.m. until Park close.
JPMorgan Chase & Co. provides various financial services worldwide. The company operates through four segments: Consumer & Community Banking, Corporate & Investment Bank, Commercial Banking, and Asset Administration.
Finally, Invesco Ltd. (NYSE:IVZ), ended its last trade with 3.39% gain, and closed at $38.99.
Invesco stated financial results for the three months ended June 30, 2015.
“In spite of a volatile global market environment, Invesco continues to provide strong, long-term investment performance to our clients,” said Martin L. Flanagan, president and CEO. “The solid investment performance across a broad range of capabilities offered positive outcomes to our clients and assisted drive strong long-term net inflows of $5.9 billion during the quarter.”
Net market losses led to a $6.2 billion decrease in AUM during the second quarter, contrast to a $18.2 billion enhance in the first quarter 2015. Foreign exchange rate movements led to a $8.5 billion enhance in AUM during the second quarter, contrast to a $13.3 billion decrease in the first quarter 2015. Average AUM during the second quarter were $810.9 billion, contrast to $795.4 billion for the first quarter 2015, an enhance of 1.9%.
Invesco Ltd. is a publicly owned investment manager. The firm provides its services to retail clients, institutional clients, high-net worth clients, public entities, corporations, unions, non-profit organizations, endowments, foundations, pension funds, financial institutions, and sovereign wealth funds. It manages separate client focused equity, balanced, and fixed income portfolios. The firm also launches equity, fixed income, commodity, multi-asset, and balanced mutual funds for its clients.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.